- Home
- AGNCM vs INM Comparison
AGNCM vs INM Comparison
Compare AGNCM & INM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AGNCM
- INM
- Stock Information
- Founded
- AGNCM 2008
- INM 1981
- Country
- AGNCM United States
- INM Canada
- Employees
- AGNCM N/A
- INM N/A
- Industry
- AGNCM Real Estate Investment Trusts
- INM Biotechnology: Pharmaceutical Preparations
- Sector
- AGNCM Real Estate
- INM Health Care
- Exchange
- AGNCM Nasdaq
- INM Nasdaq
- Market Cap
- AGNCM N/A
- INM 5.0M
- IPO Year
- AGNCM N/A
- INM N/A
- Fundamental
- Price
- AGNCM $24.59
- INM $1.85
- Analyst Decision
- AGNCM
- INM
- Analyst Count
- AGNCM 0
- INM 0
- Target Price
- AGNCM N/A
- INM N/A
- AVG Volume (30 Days)
- AGNCM 16.1K
- INM 105.5K
- Earning Date
- AGNCM 10-20-2025
- INM 11-13-2025
- Dividend Yield
- AGNCM 9.26%
- INM N/A
- EPS Growth
- AGNCM N/A
- INM N/A
- EPS
- AGNCM 0.70
- INM N/A
- Revenue
- AGNCM $956,000,000.00
- INM $4,942,633.00
- Revenue This Year
- AGNCM $12.74
- INM N/A
- Revenue Next Year
- AGNCM $59.89
- INM N/A
- P/E Ratio
- AGNCM $15.59
- INM N/A
- Revenue Growth
- AGNCM N/A
- INM 7.50
- 52 Week Low
- AGNCM $23.01
- INM $1.72
- 52 Week High
- AGNCM $25.60
- INM $8.27
- Technical
- Relative Strength Index (RSI)
- AGNCM 39.43
- INM 31.68
- Support Level
- AGNCM $24.57
- INM $2.04
- Resistance Level
- AGNCM $24.73
- INM $2.14
- Average True Range (ATR)
- AGNCM 0.11
- INM 0.11
- MACD
- AGNCM -0.00
- INM -0.03
- Stochastic Oscillator
- AGNCM 16.36
- INM 10.87
About AGNCM AGNC Investment Corp. Depositary Shares rep 6.875% Series D Fixed-to-Floating Cumulative Redeemable Preferred Stock
AGNC Investment Corp is a real estate investment trust that invests in agency residential mortgage-backed securities. The firm's asset portfolio is comprised of residential mortgage pass-through securities and collateralized mortgage obligations for which the principal and interest payments are guaranteed by a U.S. Government-sponsored enterprise, such as the Federal National Mortgage Association and the Federal Home Loan Mortgage Corporation, or by a U.S. Government agency, such as the Government National Mortgage Association. It also invests in other types of mortgage and mortgage-related residential and commercial mortgage-backed securities or other investments in or related to, the housing, mortgage, or real estate markets.
About INM InMed Pharmaceuticals Inc.
InMed Pharmaceuticals Inc is a Canada based clinical-stage biopharmaceutical company. The Company's operations consist of two operating and reportable segments, the InMed Pharma segment and the BayMedica Commercial segment. The InMed Pharma segment is largely organized around the research and development of small molecule pharmaceuticals drug candidates and the BayMedica Commercial segment is largely organized around manufacturing technologies to produce and commercialize bulk rare cannabinoids for sale as ingredients in the health and wellness industry. Its product portfolio includes INM-755, which is used for the treatment of epidermolysis bullosa; INM-088 for the treatment of glaucoma; INM-901 for Alzheimer's disease.